Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)

Completed

Phase 3 Results

Summary of Purpose

This trial will include patients who have a heart condition called atrial fibrillation. Atrial fibrillation is an abnormal rhythm (irregular beat) in the heart. Patients with atrial fibrillation have an increased chance for a blood clot to form in the heart and move to other blood vessels in the body and cause obstruction. This obstruction may damage tissue. For example, a blood clot plugging a vessel in the...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 April 2011.

1 Sep 2003 6 Oct 2003 1 Mar 2006 1 Mar 2006 1 Apr 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study

Contacts

  • Daniel E. Singer, MD; Clinical Epidermiology Unit; General Medicine Division; Massachusetts General Hospital and Harvard Medical School; Boston, MA

    alan.s.go@kp.org